0.00
price down icon100.00%   -4.97
after-market Handel nachbörslich: 4.99 4.99 +
loading

Bluebird Bio Inc Aktie (BLUE) Neueste Nachrichten

pulisher
Aug 19, 2025

Car T Cell Therapy For Multiple Myeloma Pipeline 2025: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight | Bluebird bio, Cellectis SA, Caribou Biosciences, Luminary Therapeutics - Barchart.com

Aug 19, 2025
pulisher
Aug 13, 2025

Shareholders That Lost Money on bluebird bio, Inc.(BLUE) Should Contact Levi & Korsinsky About Pending Class ActionBLUE - ACCESS Newswire

Aug 13, 2025
pulisher
Aug 11, 2025

Unexpected Shifts in the Gene Transfer Technologies Market - openPR.com

Aug 11, 2025
pulisher
Aug 11, 2025

Analyzing drawdowns of bluebird bio Inc. with statistical toolsWatchlist Summary for Active Day Traders - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

When is the best time to exit bluebird bio Inc.Weekly Price Target Forecast and Alerts - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

How moving averages guide bluebird bio Inc. tradingIntelligent Trade Forecast With AI Analytics - Newser

Aug 11, 2025
pulisher
Aug 10, 2025

Historical volatility pattern of bluebird bio Inc. visualizedSafe Entry Screening with Data Backed Analysis - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

Risk vs reward if holding onto bluebird bio Inc.Free Daily Volume Spike Trading Signals - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

BLUEBIRD BIO Earnings Preview: Recent $BLUE Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative

Aug 10, 2025
pulisher
Aug 08, 2025

FDA restricts use of bluebird's gene therapy Skysona due to increased blood cancer risk - Endpoints News

Aug 08, 2025
pulisher
Aug 08, 2025

Sickle Cell Disease Pipeline 2025: FDA Approvals, Therapies, Clinical Trials, And Latest Developments Unveiled By Delveinsight Sanofi, Novartis AG, Bluebird Biotech, Pfizer Inc., Aruvant Sciences - Menafn

Aug 08, 2025
pulisher
Aug 07, 2025

Technical analysis overview for bluebird bio Inc. stockFree Entry Plan for Oversold Reversal Stocks - Newser

Aug 07, 2025
pulisher
Aug 06, 2025

Cerebral Adrenoleukodystrophy Market: Leriglitazone, Gene Therapies Signal New Era Across 7MM | DelveInsight - Barchart.com

Aug 06, 2025
pulisher
Aug 06, 2025

Gene Therapy Market Set to Witness Significant Growth - openPR.com

Aug 06, 2025
pulisher
Aug 06, 2025

What's Going On With Bluebird Bio Stock? - 富途牛牛

Aug 06, 2025
pulisher
Aug 05, 2025

What institutional flow reveals about bluebird bio Inc.Technical Safety Zone Pattern Recognition - Newser

Aug 05, 2025
pulisher
Aug 03, 2025

Should I hold or sell bluebird bio Inc. stock in 2025Get timely alerts on top market movers - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is bluebird bio Inc. stock overvalued or undervaluedRemarkably fast returns - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is it the right time to buy bluebird bio Inc. stockMaximize your returns with portfolio optimization - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is bluebird bio Inc. a growth stock or a value stockDiscover stocks with superior performance - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What makes bluebird bio Inc. stock price move sharplyUnlock exclusive trading strategies for gains - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How strong is bluebird bio Inc. company’s balance sheetGet expert alerts on market-moving stocks - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What catalysts could drive bluebird bio Inc. stock higher in 2025Rapidly expanding wealth - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How does bluebird bio Inc. generate profit in a changing economyInvest confidently with data-driven strategies - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How does bluebird bio Inc. compare to its industry peersUnmatched market gains - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How volatile is bluebird bio Inc. stock compared to the marketFree Buy/Sell Signal Notifications - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What institutional investors are buying bluebird bio Inc. stockInvest smarter with data-backed trading alerts - Jammu Links News

Aug 03, 2025
pulisher
Aug 01, 2025

What are the technical indicators suggesting about bluebird bio Inc.Advanced Screener Ideas For Every Investor - Jammu Links News

Aug 01, 2025
pulisher
Aug 01, 2025

How many analysts rate bluebird bio Inc. as a “Buy”Low Risk Alerts Backed By Experts - Jammu Links News

Aug 01, 2025
pulisher
Jul 31, 2025

Why bluebird bio Inc. stock attracts strong analyst attentionCapital Preserving Trade Plan Templates Shared - beatles.ru

Jul 31, 2025
pulisher
Jul 28, 2025

What are the latest earnings results for bluebird bio Inc.Outstanding capital appreciation - Jammu Links News

Jul 28, 2025
pulisher
Jul 25, 2025

What drives bluebird bio Inc. stock priceOver 200% growth - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about bluebird bio Inc. stock outlookAccelerated earnings growth - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

Is bluebird bio Inc. a good long term investmentSuperior stock selection - PrintWeekIndia

Jul 25, 2025
$24.65
price up icon 0.94%
$85.04
price down icon 1.72%
$26.20
price up icon 0.73%
$110.88
price up icon 0.10%
$131.88
price down icon 0.54%
biotechnology ONC
$313.67
price down icon 0.10%
Kapitalisierung:     |  Volumen (24h):